<p>(<b>A</b>) ART suppressed plasma viremia to below detection (vRNA; solid line, closed symbols) while peripheral blood cell-associated vDNA (dashed line; open symbols) were unaffected (Day −3 vs. Day42, p = 0.63, signed rank test). (<b>B</b>) ART led to a rebound in peripheral blood CD4<sup>+</sup> T cells to pre-infection levels. (<b>C–E</b>) Drug concentrations [tenofovir (C), emtricitabine (D) or raltegravir (E)] were determined within the plasma and each of the indicated tissues. For this steady state drug concentration analysis, the 4 BLT mice in (A) were harvested 21 hours following their last ART dosing and the tissue concentrations of the antiretrovirals were determined.</p
OBJECTIVE: The ability of antiretroviral drugs to penetrate and suppress viral replication in tissue...
Background—Recent reports showed that functional control of HIV-1 infection for a prolonged time is ...
Total plasma concentrations are currently measured for therapeutic drug monitoring of HIV protease i...
<p>(A) Longitudinal analysis of RPV levels in plasma of NSG mice injected intramuscularly once with ...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
Antiretroviral therapy (ART) can reduce HIV levels in plasma to undetectable levels, but rather litt...
<p>(<b>A</b>) Longitudinal measurements of plasma viremia (red triangles) and the frequency of CD4<s...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...
*<p>n.d. = non-detectable.</p><p>- Humanized mice were sacrificed 151 days after HIV infection and...
<p>(A) Response to ART with AZT, 3TC and RTV, followed by 3TC, TDF and TMC278-LA. Note that the init...
(A) Chronic 251 cohort (n = 6) assessed. (B) Kinetics of plasma (red lines) and CSF (blue lines) vir...
<p>(A–B) Longitudinal analyses of peripheral blood plasma viral RNA (A) and the percentage of periph...
<p>(A–B) Longitudinal analyses of peripheral blood plasma viral RNA (A) and the percentage of periph...
BACKGROUND: HIV is produced in lymphoid tissues (LT) and stored on the follicular dendritic cell net...
Stably suppressed viremia during ART is essential for establishing reliable simian models for HIV/AI...
OBJECTIVE: The ability of antiretroviral drugs to penetrate and suppress viral replication in tissue...
Background—Recent reports showed that functional control of HIV-1 infection for a prolonged time is ...
Total plasma concentrations are currently measured for therapeutic drug monitoring of HIV protease i...
<p>(A) Longitudinal analysis of RPV levels in plasma of NSG mice injected intramuscularly once with ...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
Antiretroviral therapy (ART) can reduce HIV levels in plasma to undetectable levels, but rather litt...
<p>(<b>A</b>) Longitudinal measurements of plasma viremia (red triangles) and the frequency of CD4<s...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...
*<p>n.d. = non-detectable.</p><p>- Humanized mice were sacrificed 151 days after HIV infection and...
<p>(A) Response to ART with AZT, 3TC and RTV, followed by 3TC, TDF and TMC278-LA. Note that the init...
(A) Chronic 251 cohort (n = 6) assessed. (B) Kinetics of plasma (red lines) and CSF (blue lines) vir...
<p>(A–B) Longitudinal analyses of peripheral blood plasma viral RNA (A) and the percentage of periph...
<p>(A–B) Longitudinal analyses of peripheral blood plasma viral RNA (A) and the percentage of periph...
BACKGROUND: HIV is produced in lymphoid tissues (LT) and stored on the follicular dendritic cell net...
Stably suppressed viremia during ART is essential for establishing reliable simian models for HIV/AI...
OBJECTIVE: The ability of antiretroviral drugs to penetrate and suppress viral replication in tissue...
Background—Recent reports showed that functional control of HIV-1 infection for a prolonged time is ...
Total plasma concentrations are currently measured for therapeutic drug monitoring of HIV protease i...